Latest Delcath Systems, Inc. Stories

2014-03-24 08:27:23

NEW YORK, March 24, 2014 /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ: DCTH) is a specialty pharmaceutical and medical device company mainly focused on the treatment of primary and metastatic liver cancers. Liver cancer is the sixth most common cancer in the world with nearly 780,000 new cases diagnosed each year. It is estimated by Global Industry Analysts (GIA) that the potential market for liver cancer worldwide will exceed $2 billion by the year 2015. Primary liver cancer...

2014-03-21 20:21:18

Editor Note: For more information about this release, please scroll to bottom. LONDON, March 21, 2014 /PRNewswire/ -- On Thursday, March 20, 2014, the NASDAQ Composite ended at 4,319.29, up 0.27%, the Dow Jones Industrial Average gained 0.67% to reach 16,331.05, and the S&P 500 closed at 1,872.01, up 0.60%. The gains were broad based as nine of ten sectors finished higher. The S&P 500 Health Care Sector Index finished the day 0.02% lower at 686.29, whereas, the index...

2014-03-12 16:26:26

- Conference Call and Webcast Today at 4:30 p.m. ET - NEW YORK, March 12, 2014 /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ: DCTH) today reported financial results and operational developments for the fiscal fourth quarter and full year ended December 31, 2013. Developments for the quarter and recent weeks subsequent to quarter end are as follows: -- The Company's cash and cash equivalents increased in the fourth quarter 2013 and the first quarter of 2014; cash position as of...

Word of the Day
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.